Midregion Prohormone Adrenomedullin and Prognosis in Patients Presenting With Acute Dyspnea: Results From the BACH (Biomarkers in Acute Heart Failure) Trial

Study Questions:

Do levels of midregion prohormone adrenomedullin (MR-proADM) predict prognosis in patients presenting with acute dyspnea?